Hodgkin lymphoma, Lymphoma
Results
Phase 2
This trial looked at a drug called panobinostat for people with Hodgkin lymphoma. It was open to people whose Hodgkin lymphoma had come back after high dose chemotherapy and a stem cell transplant, or had not responded to this treatment.
Recruitment start: 16 September 2008
Recruitment end: 30 October 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Radford
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 12 July 2015
CRUK internal database number: 4389
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
